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ABSTRAK 
Kajian sistematik terhadap kesitotoksikan nanopartikel logam 
berperantara tumbuhan 
 
Nanoteknologi menawarkan kegunaan yang meluas dalam pelbagai bidang 
seperti kejuruteraan, telekomunikasi, pengiklanan, tekstil, kosmetik, dan juga 
perubatan. Keunikan nano-bahan membolehkannya digunakan sebagai agen 
anti-kanser mahupun penghantar ubat dalam bidang perubatan, terutamanya 
nano-bahan yang diperoleh daripada tumbuhan. Walau bagaimanapun, isu bio-
keselamatan nanopartikel logam yang digunakan sebagai agen anti-kanser 
harus dititikberatkan. Oleh itu, kajian ini dijalankan bagi membandingkan 
kesitotoksikan nanopartikel logam berperantara tumbuhan, berdasarkan 
potensi, kecenderungan jenis sel kanser, serta indeks terapeutik agar calon 
agen anti-kanser yang terbaik dan selamat dapat di temui. Kajian ini juga cuba 
mengaitkan faktor saiz dan rupa bentuk dengan potensi kesitotoksikan suatu 
nanopartikel. Pencarian artikel kajian dijalankan menggunakan pangkalan data 
elektronik seperti Science Direct, Elsevier, PubMed, Springer Link dan Google 
Scholar. Selain itu, laman rangkaian sosial akademik, ResearchGate turut 
digunakan sebagai sumber artikel kajian rujukan. Kata kunci seperti biosintesis, 
sintesis tumbuhan, berperantara tumbuhan, nanopartikel logam, kesitotoksikan 
dan anti-kanser digunakan semasa proses pencarian dijalankan. Semua jenis 
kajian yang memenuhi kriteria rangkuman dan pengecualian telah 
dipertimbangkan tidak kira apa jua keputusannya. Maklumat dan data daripada 
76 artikel kajian yang terpilih telah diambil kira dan dikaji. Indeks terapeutik 
digunakan dalam kajian ini sebagai panduan keselamatan bagi sebatian yang 
 
xi 
 
dikaji. Kebanyakan kajian yang terpilih menunjukkan bagaimana kesitotoksikan 
nanopartikel logam berperantara tumbuhan bergantung pada masa dan/atau 
dos. Nanopartikel perak didapati lebih sitotoksik berbanding nanopartikel emas 
daripada tumbuhan yang sama; Cassia auriculata, Commelina nudiflora, dan 
Plumbago zeylanica digunakan bagi sintesis tersebut tanpa mengira jenis sel 
kanser yang terlibat. Kesitotoksikan didapati berkadar songsang berbanding 
saiz nanopartikel. Sebahagian besar nanopartikel logam berperantara 
tumbuhan didapati berbentuk sfera, dengan bentuk sfera dan hampir-sfera yang 
paling kerap di temui dengan mod populasi LD50 1–20 µg/mL, diikuti bentuk 
lain; segitiga, heksagon dan rod yang menunjukkan potensi sitotoksik yang 
lebih rendah. Nanopartikel logam daripada Abutilon inducum, Annona 
squamosa, Butea monosperma, Couroupita guainensis, Gossypium hirsutum, 
Indoneesiella echioides, dan Melia azedarach didapati selamat digunakan 
sebagai agen anti-kanser kerana mempunyai indeks terapeutik bernilai 2.0 dan 
ke atas apabila diuji terhadap sel kanser mahupun sel normal manusia. Hasil 
keputusan kajian ini mencadangkan agar kajian lebih mendalam dijalankan 
terhadap agen antikanser berpotensi yang disenaraikan untuk mengetahui lebih 
lanjut tentang fungsi farmakodinamik/toksikodinamik dan 
farmakokinetik/toksikokinetik tumbuhan tersebut dalam usaha untuk 
mengurangkan penyakit kanser, iaitu Beban Penyakit Global (Global Burden of 
Diseases/GBD) dan juga penyebab kematian kedua tertinggi di dunia. 
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ABSTRACT 
A systematic review on cytotoxicity of plant-mediated metallic 
nanoparticles 
 
Nanotechnology has undeniably offered a variety of applications, ranging from 
engineering, telecommunication, advertising, textile, cosmetics and even 
medicine. Due to its unique properties, nanomaterials suggest a promising use 
in medicine such as being anti-cancer agents along with drug-carriers, 
especially those which are derived using the green method. However, concern 
arises on the bio-safety of metallic nanoparticles used as anti-cancer agents. 
Therefore, this systematic review aims to compare the cytotoxicity of plant-
mediated metallic nanoparticles based on its potency, cancer cell type 
susceptibility, and therapeutic index in the hopes of finding the most promising 
anti-cancer agents. This study also correlates nanoparticle size and morphology 
with the potency of cytotoxicity. A literature search was conducted on electronic 
databases including Science Direct, Elsevier, PubMed, Springer Link and 
Google Scholar. In addition, an academic social networking site, ResearchGate 
was also used to obtain research articles. Keywords such as biosynthesis, plant 
synthesis, plant-mediated, metallic nanoparticle, cytotoxicity and anticancer 
were used in the literature search. All types of research which met the inclusion 
and exclusion criteria were considered regardless of the results being positive, 
negative or null. Data and information from the 76 selected articles were 
extracted and synthesised. Therapeutic index was used as a safety measure for 
the studied compound of interest. Most research showed the cytotoxicity 
property of plant-mediated metallic nanoparticles and cytotoxicity being time 
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and/or dose-dependent. Silver nanoparticles demonstrated a higher cytotoxicity 
potency as compared to gold nanoparticles of the same plants; Cassia 
auriculata, Commelina nudiflora and Plumbago zeylanica were used for the 
synthesis irrespective of the cell types used. Cytotoxicity is inversely 
proportional to size. Plant-mediated metallic nanoparticles were predominantly 
spherical in shape where spherical and quasi-spherical appeared most often 
with LD50 of 1–20 µg/mL being the mode of populations, followed by other 
shapes; triangular, hexagonal and rods showing less potency. Abutilon 
inducum, Annona squamosa, Butea monosperma, Couroupita guainensis, 
Gossypium hirsutum, Indoneesiella echioides, and Melia azedarach metallic 
nanoparticles were acceptably safe as anti-cancer agents, having a therapeutic 
index of 2.0 and above when tested on both cancer cells and normal human 
cells. Results from this study suggest a focus on the listed potential anti-cancer 
agents for further investigations on their pharmacodynamic/toxicodynamic and 
pharmacokinetic/toxicokinetic actions in hopes of reducing cancer, the Global 
Burden of Diseases (GBD) and the second leading cause of mortality. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of the study 
Nanoparticles are the fundamental component in nanotechnology. It is 
intentionally designed and engineered with desired physical, chemical and 
biological properties moulded to meet the needs of specific applications. To 
date, nanotechnology has been embraced by industrial sectors due to its 
tremendous applications of nanoparticles and nanomaterials in diverse fields 
from engineering, telecommunication, advertising, electronics, textile, sports 
and toys, space and defense, cosmetics, domestics and even in medical.  
 
The use of nanoparticles and nanotechnology, additionally offer great potential 
in medicine ranging from diagnostic imaging, cancer therapy, gene therapy as 
well as drug delivery system. In diagnostic imaging, nanoshell-enhanced optical 
coherence tomography has improved detection of disease (Low et al., 2006). As 
drug delivery system, gold nanoparticles coated with polyethylene glycol (PEG) 
were loaded with cytokine, Tumour Necrosis Factor alpha (TNF-α) to maximise 
tumour killing (Visaria et al., 2006). Additionally, gold nanoparticles were used 
with paclitaxel, a chemotherapy drug in cancer treatment to promote anti-
proliferative effect and apoptosis in human hepatoma (Hep-G2) cells (Wei et al., 
2007).  
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1.2 Problem statement and rationale of the study 
Nanotechnology suggests promising applications in wide areas of medicine 
such as new anti-bacterial agents in finding better treatment and strategy in 
combating cancers. Numerous studies have been conducted to develop anti-
cancer agent using metallic nanoparticles via various methods; mechanical 
attrition, laser ablation, photo reduction, chemical electrolysis and also with the 
use of organisms like bacteria and plants. Plant-mediated metallic nanoparticles 
have become increasingly famous and researched as cytotoxic agents for the 
past 10 years as a better substitute for metallic nanoparticles which are 
chemically or physically derived.  
 
Multiple studies have shown on the potential of plant-mediated metallic 
nanoparticles as effective cytotoxic agents against various cancers such as lung 
cancer (A549) cells (Kuppurangan et al., 2016), liver cancer (Hep-G2) cells 
(Selvarani, 2015), colorectal cancer (HT29) cells (Bupesh et al., 2016; Mata et 
al., 2016), breast cancer (MCF7) cells (Rashidipour et al., 2014), and brain 
cancer (U87) cells (Mishra et al., 2016). Despite all these thrilling potentials, 
concerns arise on the safety issue of developed anti-cancer agents since a 
potent anti-cancer agent may not only kill cancer cells but also other normal 
healthy cells when used as a treatment. 
 
An ideal drug or treatment should have properties which include selective, 
specific to target site, potent (<100mg/day), safe and effective other than 
minimal food/drug interaction, with convenient dosing frequency and no 
requirement for blood level monitoring (Spector, 2002). It is desirable to develop 
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an anti-cancer agent which is stable, specific towards the target site, has a wide 
therapeutic index, bio-compatible, biodegradable with minimal side effects, 
reasonably simple reproductive and cost effective. Based on previous studies, 
these plant-mediated metallic nanoparticles are effective as cytotoxic agents 
and have reasonably simple production method at low cost but its safety as 
cytotoxic agents has not been extensively addressed. Additionally, which novel 
plant-mediated metallic nanoparticles to be investigated further as anti-cancer 
agents also becomes a question. Thus, this project systematically reviews and 
compares the efficacy and safety of plant-mediated metallic nanoparticles as 
cytotoxic agents in aiding the associated decision making plus hoping to reduce 
the numbers of medicine development failures. 
 
1.3 Study objectives 
This systematic review aims to: 
i. Compare the cytotoxicity potency of plant-mediated metallic 
nanoparticles based on recent studies; 2006 to 2017.  
ii. Determine the most promising plant-mediated metallic nanoparticles as 
anti-cancer agents based on its potency, cancer cell type susceptibility, 
and therapeutic index. 
iii. Correlates nanoparticles size and morphology with the potency of 
cytotoxicity. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Nanoparticles 
A particle is defined as a small object which behaves as a whole unit while 
nanoparticle refers to organic or inorganic particle having nanoscale size 
ranging from 1 to 100 nanometers (nm) with one or more dimensions (Williams, 
2008). Nanoparticles exhibit significant differences in physical as well as 
chemical properties based on its size, distribution, and morphology in 
comparison with bulk material or fine particles in which the nanoparticles are 
made of (Cao, 2004). Gold per se is yellow-orange in colour, while gold 
nanoparticles in liquid solution with the size of less than 100 nm have an 
intense red colour. The melting point differs, 1064 °C and 300 °C for gold slabs 
and gold nanoparticles respectively. The synthesised nanoparticles display 
properties which are new or greatly improved and are unique due to their large 
surface area in respect to their microscopic size. Moreover, nanoparticles also 
have exclusive optical and electrical properties besides the previously 
mentioned thermal properties. 
 
2.2 Nanoparticles synthesis 
The production of nanoparticles is achieved by several means. Nanoparticles 
synthesis methods are classified into three main categories namely physical, 
chemical, and biological (Iravani et al., 2014). Physical methods include 
mechanical attrition, thermal decomposition, and laser ablation. In 2006, a study 
conducted by Kim et al. has successfully synthesised copper nanoparticles 
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using thermal decomposition. Sylvestre et al. (2004) produced gold 
nanoparticles using laser ablation yielding extremely small, stable and 
homogenised colloids with a size range of 2.0 to 2.4 nm and dispersion size of 
1.0 to 1.5 nm. This technique was also used in an attempt to generate silver 
nanoparticles which result in highly pure nanoparticles being produced, thereby 
eliminating solvent contamination (Tsuji et al., 2002). The nanoparticles are also 
found to be uniformly distributed. However, physical methods require the use of 
large production space and a huge amount of energy to ensure that the desired 
temperature at which reduction occurs can be reached on top of additional time 
required to maintain thermal stability in ensuring homogeneous nanoparticles 
being produced (Iravani et al., 2014). 
 
Chemical method, on the other hand involves metal salts reduction, 
microemulsion, radiation, photo-reduction, chemical electrolysis, microwave 
assisted synthesis and/or sonochemical reduction. Metal salt reduction is the 
most common chemical method used. Various reducing agents are used such 
as ascorbate, elemental hydrogen, sodium citrate, sodium borohydride, Tollens 
reagent, and polyethylene glycol (PEG) copolymers to perform reduction 
reactions. Chemical methods allow nanoparticles synthesis to occur at room 
temperature in contrast to thermal decomposition method (Troupis et al., 2002). 
Furthermore, a short time is required for metallic nanoparticles to be produced. 
Nonetheless, use of surfactant or surface passivator reagent or stabiliser is 
necessary to prevent nanoparticles from aggregation as reported by Nayak et 
al. (2011) and Crooks et al. (2001).  Surface passivator thiourea was used in 
producing agglomerate-free cadmium nanoparticles (Pattabi et al., 2000) while 
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stabiliser mercaptoacetic acid was used in producing agglomerate-free zinc 
oxide nanorods (Song et al., 2008). Disappointingly, these chemical methods 
use chemical substances which are toxic to human health and the environment 
especially when used in large quantities.   
 
Biological method uses organisms ranging from simple prokaryotic bacterial 
cells to eukaryotic fungi and plants to synthesise nanoparticles (Mohanpuria et 
al., 2008). Exploitations on microorganisms and plants as nanofactories has 
been recognised as green, efficient and convenient (Singh et al., 2016). In 
contrast to physical and chemical methods, synthesis of nanoparticles using 
biological methods is environmentally friendly, inexpensive, simple and cost-
effective.  Biologically synthesised metallic nanoparticles are favoured as 
chemical and physical methods are fraught with many drawbacks including the 
use of toxic solvents, generation of hazardous by-products and high energy 
consumption (Thakkar et al., 2010). Stable silver nanoparticles were 
successfully developed in a rapid, inexpensive and energy-efficient method 
using tannic acid from plant extracts at room temperature and this method is 
free from the use of toxic solvents which are hazardous to the environment 
(Sivaraman et al., 2009). Furthermore, narrow distribution size and reduction of 
polydispersity can be manipulated with the use of microorganisms in generating 
metallic nanoparticles (Singh et al., 2016).  
 
Although stable nanoparticles are produced using various known biosynthesis 
methods, novel plant-mediated nanoparticle synthesis is preferred over others 
in addition to biologically active plant compounds could be exploited as key 
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resources of the green synthesis (Naheed Ahmad et al., 2010). Consistent with 
the previous statement, metallic nanoparticles produced by medicinal plants are 
found to be pharmacologically active possibly due to the pharmacologically 
active compound incorporated into it (Singh et al., 2016). Various plant parts 
such as leaves, stems, roots, fruits (Singh et al., 2016), latex (Valodkar et al., 
2011; Rajkuberan et al., 2016), flowers (Remya et al., 2015; Mata et al., 2015b) 
even fruit peel (Zhou et al., 2014; Yang et al., 2014) and its extracts could be 
used. Apart from that, plant-mediated nanosynthesis does not involve 
complicated process of intracellular synthesis, multiple purifications, and 
maintenance of microbial cells (Mohanpuria et al., 2008). Several mechanisms 
were suggested on plant-mediated nanosynthesis but up to this date, the exact 
mechanism is yet to be completely elucidated (Baker et al., 2013; Singh et al., 
2016).  
 
Combination methods involving both biological and chemical have also been 
used in synthesising nanoparticles (Saifuddin et al., 2009). In recent time, 
monodispersed biogenic gold nanoparticles were derived using Areca catechu 
nut under microwave irradiation which showed anti-cancer effect on HeLa cells 
and also anti-bacterial activity against a broad spectrum of pathogens (Rajan et 
al., 2015). Although various methods are used to synthesise nanoparticles, new 
and improved methods are still being investigated and developed to create a 
better device or ideal process in obtaining highly purified stable nanoparticles 
and higher mass production with lower cost involved. In addition to that, a 
method which has enhanced control over the produced nanoparticle size, size 
distribution, shape, aggregation, and stability are also desired for higher 
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reproducibility purpose in developing metallic nanoparticles for various uses and 
applications such as biocompatible new anti-cancer agents and nanosize drug 
delivery systems. 
 
2.3 Cancer and its current treatment 
Cancer is a major health problem worldwide. According to the National Cancer 
Institute of United States, cancer is defined as a collection of diseases involving 
abnormal cell growth beyond control which has the potential of invading other 
parts of the body. It is listed as one of the Non-Communicable Diseases (NCDs) 
in Global Burden of Diseases (GBD) with the second leading cause of mortality 
after cardiovascular disease, accounting deaths of 8.8 million people worldwide 
in 2015, according to the GBD 2015 Study and World Health Organisation 
(WHO). From the same sources, common cancer-related mortality comprises of 
lung cancer as the main lead with approximately 1.69 million deaths, followed 
by liver cancer with 788 000 deaths, colorectal cancer with 774 000 deaths, 
stomach cancer 754 000 deaths and breast cancer with 571 000 deaths.  
 
Currently, there are several strategies used to combat cancer. Choices of 
treatment include surgery, radiation therapy, chemotherapy, hormonal therapy, 
targeted therapy, angiogenesis inhibition and also immunotherapy such as 
monoclonal antibody therapy, depending on the type/location of the cancer, its 
stage as well as patient’s general health status. The main goal of cancer 
treatment is to eradicate cancer cells and prolong life. Even though multiple 
treatment options are present, the success rate of these strategies varies 
between each type/location of the cancer and its stage. In addition, currently 
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available treatments may or may not be curative without the exception of 
numerous challenges arises from the selected treatment courses ranging from 
complications and adverse reactions. Patients who survived cancer surgery 
faces risk of complications such as sepsis, cognitive impairment as well as 
chronic pain. Radiation therapy comes with the risk of cataract, infertility and 
secondary cancer such as skin cancer. Chemotherapy, on the other hand, 
comes with multiple adverse reactions including bone marrow toxicity, 
irreversible nerve damages, and even secondary cancer formation. 
Furthermore, multidrug resistance has become a major reason why 
chemotherapy fails to eradicate cancer (Donnenberg et al., 2005; Ozben, 2006; 
Housman et al., 2014).  Targeted therapy, angiogenesis inhibition, and 
immunotherapy are still under research phases and yet to be available in 
healthcare facilities.  
 
Since nanotechnology’s arising, the use of nanoparticles as potential strategies 
in combating cancer have been extensively studied for the past decade. 
Nanoparticles are used as drug delivery system for chemotherapy drugs to 
overcome the issue of multidrug resistance due to its ability to permeate and 
accumulate in cells without being detected by the multidrug resistance mediator, 
P-glycoprotein (Cho et al., 2008).  Multiple studies have shown the potential of 
metallic nanoparticles as effective cytotoxic agents against various cancers 
such as human epithelial lung carcinoma (A549) cells (Mukundan et al., 2015; 
Kuppurangan et al., 2016), human hepatocellular carcinoma (Hep-G2) cells 
(Selvarani, 2015), human colorectal cancer (HT29) cells (Bupesh et al., 2016; 
Sengani et al., 2016), human breast cancer (MCF7) cells (Jeyaraj et al., 2013; 
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Mittal et al., 2015),  human cervical cancer (HeLa) cells (Dipankar et al., 2012; 
Chanthini et al., 2015) and also human glioblastoma (U87) cells (Mittal et al., 
2015; Mishra et al., 2016). Yet, safety issue of these synthesised cytotoxic 
nanomaterials remains huge concerns before research in the further stage is 
carried out in an attempt to reduce the numbers of medicine development 
failures. 
 
2.4 Research Gap 
Drugs are not always effective and completely safe. The properties of an ideal 
drug includes selective, specific, localised effect, potent, and consistent efficacy 
with minimal adverse reactions (Spector, 2002). Therapeutic index is one of the 
measures of toxicity. It is often used to measure the safety of drug for a 
particular treatment. Therapeutic index shows a quantitative relationship of a 
drug efficacy (pharmacology) and safety (toxicology) using a range of endpoints 
(Muller et al., 2012). It is defined as the ratio of the median lethal dose (LD50) to 
the median effective dose (ED50). Median lethal dose (LD50) is the dose 
required to kill half (50%) of the tested population after a specified test duration 
whereas median effective dose (ED50) is the dose required to achieve the 
desired outcome or response in half (50%) of the tested population.   
 
In clinical practice, therapeutic index is regarded as the range of doses in which 
a medication appeared to be effective in clinical trials for a median of 
participants without causing unacceptable adverse effects (Tamargo et al., 
2015). Drugs with narrow therapeutic index have small ratio or differences in 
dose which may lead to dose-dependent, serious therapeutic failures and/or 
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adverse drug reactions such as persistent, irreversible, slowly reversible, 
disability or even fatality (Yu et al., 2015). Cytotoxic agents are among the 
examples of drugs with narrow therapeutic index other than aminoglycosides, 
digoxin, levothyroxine, warfarin, phenytoin, theophylline, and lithium carbonate.  
 
A potent cytotoxic agent may not only kill the rapidly growing cancer cells 
effectively but may also kill other normal healthy cells efficiently during the 
treatment course. Thus it is highly desirable to develop cytotoxic agents which 
have high selectivity in eliminating cancer cells yet safe enough not to eradicate 
rapidly growing normal cells when administered. Therefore, estimation of 
therapeutic index for newly engineered plant-mediated metallic nanoparticles as 
cytotoxic agents could help in determining its safety profile. Improvement in 
identification and assessment of drug safety is important during drug 
development and pharmacovigilance (Ray, 2009). Therapeutic index 
determination is one of the improved strategies aiding to identify both suitable 
and unsuitable drug candidates in the early research phase for associated 
decision making so that it may reduce the number of expensive research 
failures in the late stage of clinical trials (Muller et al., 2012).   
 
A drug having therapeutic index of less than one (< 1) is regarded as 
acceptable for oncology indications. However, a drug which is initially 
developed for oncology indications having a reasonable therapeutic index of 
more than one (> 1) holds potential expansions to be studied and used for other 
indications due to its sensible safety profile (Muller et al., 2012). One example is 
Imatinib, an antineoplastic drug for leukaemia and gastrointestinal stromal 
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tumour which has been explored for use in treating pulmonary arterial 
hypertension. Thus, identification of therapeutic index for plant-mediated 
metallic nanoparticle may also estimate whether these compound of interests 
may be use safely for indications other than cancer treatment. 
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CHAPTER 3 
METHODOLOGY 
 
3.1 Search process 
Search strategy was planned and constructed. The literature search was 
executed on full-text electronic databases such as Science Direct, Elsevier, 
PubMed, and Springer Link. In addition to the stated databases, a general 
search engine such as Google Scholar was also used. An academic social 
networking site, ResearchGate, was in addition used to obtain the research 
articles. Keywords such as biosynthesis, plant synthesis, plant-mediated, 
metallic nanoparticle, cytotoxicity and anticancer were used during the literature 
search. A reviewer (author) independently screened the titles and abstracts of 
the citations and retrieved relevant articles from the mentioned full-text 
electronic journal databases.  
 
With the objective of complementing the database searches, non-automated 
manual searches were conducted on the references within the selected articles. 
After the application of the search strategy, two examiners (supervisor and co-
supervisor) reviewed on the screened research titles and abstracts. 
Documentation on the whole search process was carried out to ensure 
transparency, replicability and feasibility to reanalyse. Endnote software Version 
X7 was used as a reference manager. Full text of each identified study was 
retrieved by author. 
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3.2 Study selection 
All types of research specifically in vitro, in vivo and ex vivo studies and reviews 
which met the inclusion and exclusion criteria were considered regardless the 
results are positive, negative or null to diminish selection bias. Pre-clinical and 
clinical trials were not included as there were no such studies conducted to this 
date.  
 
3.2.1 Inclusion criteria 
For inclusion in this review, literatures fulfilling below-mentioned criteria were 
collected: 
i. Metallic nanoparticles; gold (Au), silver (Ag) 
ii. Biologically synthesised using plant 
iii. Recent published studies conducted between 2006 to 2017 (including in-
press articles) 
iv. All types of studies; in vitro, in vivo, ex vivo, review  
 
3.2.2 Exclusion criteria 
All searched literatures collected having any of these criteria were excluded 
from this study: 
i. Metallic nanoparticles derived from non-vascular plant (fungus, 
seaweeds, mushrooms) 
ii. Metallic nanoparticles derived from undefined plant (specific pure 
compound from unknown plant used in the biosynthesis) 
iii. Combined synthesis of metallic nanoparticle with chemical or physical 
method 
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iv. Combined metallic nanoparticles 
v. Studies without available data 
vi. Articles which were written in language other than English 
 
The flow chart demonstrates the results from the literature search obtained from 
all databases mentioned on the association between plant-mediated metallic 
nanoparticles and cytotoxic activity. 
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Figure 3.1: Methodology Process 
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3.2.3 Study quality assessment 
Titles and abstracts for all 796 articles were screened with only 88 articles 
related to the research question. For all the 88 potentially eligible articles, the 
following criteria were used to assess the quality of the study: 
i. Clearly defined control/comparison group 
ii. Duration of exposure clearly stated 
iii. Method conducted at 37°C to mimics human body temperature 
iv. Clearly defined measured outcomes (LD50, IC50, GI50, cell viability, cell 
death) 
v. Ethical standards carried out and maintained, if relevant 
vi. Reliable method used to measure outcomes 
vii. Multiple measurements of outcome conducted (at least triplicates) 
viii. Actual data or evidence available on treatment outcomes 
ix. Outcomes reported separately for each treatment 
x. Clear statement of findings 
xi. Appropriate statistical analysis used 
 
The above study criteria were used aiming at eliminating attrition biases, raised 
from incomplete reporting of data for each outcome, in addition to reporting 
biases from selective reporting of positive outcomes. Several appraisal 
guidelines and checklists were used in developing the study criteria including: 
i. Preferred Reporting Items for Systematic review and Meta-Analysis 
Protocols (PRISMA-P) 2015 checklist 
ii. Risk of Bias Assessment tool for Non-randomized Studies (RoBANS)  
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3.3 Data extraction 
Data and information extraction from the selected studies was carried out by 
author. The following items were gathered for the cytotoxicity activity of plant-
mediated metallic nanoparticles: 
i. Plant used 
ii. Plant part used 
iii. Type of normal cells used 
iv. Type of cancer cells used 
v. Duration of cells exposed to synthesised nanoparticle 
vi. Median lethal dose (LD50) or median inhibition concentration (IC50) for 
      each cell type tested 
vii. Response relationship (Dose / Time-dependent) 
viii. Mechanism of cytotoxicity 
ix. Synthesised nanoparticle size 
x. Synthesised nanoparticle morphology 
 
3.4 Data synthesis 
The descriptions of evidence were presented in tabular format. In addition, 
therapeutic index for the synthesised plant-mediated metallic nanoparticles was 
calculated by author for studies which conduct cytotoxicity testing on both 
cancer and normal cell types. The therapeutic index is often used to measure 
the safety of a drug for a particular treatment. It is defined as the ratio of the 
median lethal dose (LD50) to the median effective dose (ED50) (Clark et al., 
2012). 
 Therapeutic Index (TI)    =        Median Lethal Dose (LD50) 
                                                  Median Effective Dose (EC50) 
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3.5 Data analysis 
Correlation between plants synthesised metallic nanoparticles size and its 
morphology to cytotoxicity potency were analysed in the current study. Results 
were presented in graphical format. Based on the availability of reasonable 
therapeutic index, potential plant-mediated metallic nanoparticles with most 
promising as anti-cancer agents were selected. 
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CHAPTER 4 
RESULTS AND DISCUSSION 
 
4.1 Search results 
This systematic review preliminary search results using Science Direct 
database started on November 11, 2016 yields 319 articles. Subsequently, 
search results from PubMed database on November 30, 2016 yielded 17 
articles. On December 8, 2017 another search using Springer Link database 
was conducted producing 291 articles. A general search engine, Google 
Scholar was also used to search for articles related to keywords on December 
16, 2017 and 160 articles were retrieved. Lastly, an academic social networking 
site, ResearchGate was used enabling 9 articles retrieved. Afterward, all articles 
were imported to Endnote software Version X7, which was used as the 
reference manager. After the importation, results from databases were merged 
with a total of 796 articles retrieved and 19 duplicates were removed. Abstract 
screening of articles yielded 671 articles which were unrelated to the research 
question. A remaining of 106 articles was potentially eligible.  
 
A total of 18 studies were later excluded due to the pre-set exclusion criteria: 
i. Non-vascular plants (n = 10) 
ii. Combined synthesis (n = 1) 
iii. Combined metallic nanoparticles (n = 0) 
iv. Undefined plant used (n = 7) 
v. Language other than English (n = 0)  
 
